SFN 2017
Selective enzyme block reveals new treatment for fragile X
A drug that selectively blocks one form of an enzyme called GSK-3 prevents seizures and improves cognitive deficits in a mouse model of fragile X syndrome.
Spectrum: Autism Research News
NEWS /
Society for Neuroscience 2017
November 2017
SFN 2017
Experimental Huntington’s drug improves gait in Rett mice
A candidate drug in clinical trials for Huntington’s disease reverses gait problems in a mouse model of Rett syndrome.
1 Comment
SFN 2017
Maternal asthma alters immune cells in fetal brain
Mouse pups exposed to an immune response in the womb show autism-like behaviors and altered gene expression in brain cells called microglia.
0 Comments
SFN 2017
Magnetic stimulation bares imbalance of activity in fragile X brains
Researchers have used transcranial magnetic stimulation to show that people with fragile X syndrome have weak ‘inhibitory’ signals, those that dampen neuronal activity in the brain.
0 Comments
SFN 2017
‘Mini-brains’ mirror fetal brain development
Spheres of brain cells derived from a fetal skull have gene expression patterns similar to those in brain tissue from the same fetus.
0 Comments
SFN 2017
AI interprets marmosets’ trills, chirps and peeps
New artificial intelligence software can decode conversations between small monkeys called marmosets.
0 Comments
SFN 2017
Grouping people with autism masks variations in visual learning
Some young children with autism excel on tests in which they must learn to connect visual cues.
0 Comments
SFN 2017
Missing brain wave may explain language problems in nonverbal autism
Nonverbal children with autism don't show the typical wave of brain activity involved in linking objects with their names.
3 Comments
SFN 2017
Rett syndrome mutation’s effects vary by cell type
Mutations in the Rett syndrome gene MECP2 have different effects on subtypes of neurons.
0 Comments
SFN 2017
Scientists move closer to gene therapy for Rett syndrome
A virus that delivers a working copy of the Rett syndrome gene to the brain improves features of the condition in mice, and appears to be safe in monkeys.